Integra Lifesciences Holdings Corp (NAS:IART)
$ 25.99 0.69 (2.73%) Market Cap: 2.05 Bil Enterprise Value: 1.55 Bil PE Ratio: 51.98 PB Ratio: 0.71 GF Score: 81/100

Integra Lifesciences Holdings Corp at Piper Sandler Healthcare Conference Transcript

Nov 28, 2023 / 09:00PM GMT
Release Date Price: $39.06 (+0.98%)
Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

' -

All right. Good afternoon, everybody. Thanks so much for joining us. Matt O'Brien. I cover medical technology here at Piper Sandler. I'm very fortunate to have Integra with us here. From the company is Jan, who is the CEO, and then a couple of folks from IR are out in the audience. So thanks so much for coming out. I really do appreciate it.

Jan De Witte
Integra LifeSciences Holdings Corporation - President, CEO & Director

Great to be here, Matt.

Questions & Answers

Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

' -

Excellent. So maybe start a little bit with Q3. It was a little bit better than you expected, a little more stable than I think a lot of folks, I guess, generally, were expecting for Medtech. So what did you see in Q3? And then the early days of Q4 that, prior to the earnings call, what were you seeing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot